Summit Therapeutics Inc. reports financial results in SEC 8-K

Summit Therapeutics Inc. filed an 8-K covering results of operations or financial condition, charter, bylaw or fiscal-year changes, and a shareholder vote. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.